Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

944 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-10

Study Completion Date

2023-02-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Family-supported Smoking Cessation for Chronically Ill Veterans

NCT00448344

Chronic Disease Neoplasm Cardiovascular Disease +3 more

COMPLETED NA

Proactive Tobacco Treatment for Veterans

NCT00608426

Smoking Cessation Smoking Tobacco

COMPLETED NA

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

NCT03315910

Smoking Cessation

ACTIVE_NOT_RECRUITING PHASE4

Proactive Outreach for Smokers in VA Mental Health

NCT01737281

Smoking

COMPLETED NA

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

NCT03059940

Smoking Cessation

ACTIVE_NOT_RECRUITING EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lung cancer screening process. Key proactive elements include proactive telephone outreach to all current smokers by a VA Quitline counselor that follows mailed results letters, and providing providers guidance in offering proactive cessation medication support as part of the lung cancer screening process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Reduction Tobacco Use Tobacco Smoking Tomography Lung Diseases Lung Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Unstructured care

Providers in this arm will continue to provide care as usual during lung cancer screening, with no intervention from the study team.

Group Type NO_INTERVENTION

No interventions assigned to this group

Proactive care

Providers in this arm will receive guidance from the study team about offering lung cancer screening patients proactive cessation care, including cessation medications and behavioral telephone counseling.

Group Type EXPERIMENTAL

Unsigned note to provider about cessation medication prescription

Intervention Type BEHAVIORAL

For patients of providers assigned to the proactive study group, a local coordinator will review the patient's cessation medication history. If the patient is not currently being provided cessation support medication, the coordinator will enter a note for the provider about the recommended medication indicated by VA formulary guidelines.

Proactive Telephone Counseling from VA Quitline

Intervention Type BEHAVIORAL

Patients of providers assigned to the proactive study group will be contacted by specially trained counselors at the VA Quitline. Counselors will attempt to provide two sessions of proactive telephone support.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unsigned note to provider about cessation medication prescription

For patients of providers assigned to the proactive study group, a local coordinator will review the patient's cessation medication history. If the patient is not currently being provided cessation support medication, the coordinator will enter a note for the provider about the recommended medication indicated by VA formulary guidelines.

Intervention Type BEHAVIORAL

Proactive Telephone Counseling from VA Quitline

Patients of providers assigned to the proactive study group will be contacted by specially trained counselors at the VA Quitline. Counselors will attempt to provide two sessions of proactive telephone support.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Providers who schedule patients for a lung cancer screening at either of the two VA sites.
* Patients who participate in lung cancer screening and are current smokers at the time of scheduling their screening exam.

Exclusion Criteria

* Providers who currently systematically prescribe cessation support medication to all current smokers will be excluded.
* Patients with urgent findings requiring biopsy/immediate attention on the screening CT will be excluded.
* Patients with a prior diagnosis of lung cancer or who are receiving active therapy for any cancer, except skin cancer, will be excluded.
* Patients previously diagnosed with cognitive impairment, dementia, or severe behavioral disorders, or have an indication in chart review of difficulty communicating or participating in telephone counseling sessions will be excluded.

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No